US Pharma Marketing“There’s not much more to say for CVS’ 2Q other than... wow,” one analyst commented. CVS also announced a new GLP-1 deal with Eli Lilly.
CVS triples net income thanks to booming health plan profitability
“There’s not much more to say for CVS’ 2Q other than... wow,” one analyst commented. CVS also announced a new GLP-1 deal with Eli Lilly.
Source: Healthcare Dive